piperazine has been researched along with Koch's Disease in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A piperazine-containing benzothiazinones lead compound PBTZ169, served as DprE1 inhibitor, displays nanomolar bactericidal activity against Mycobacteria tuberculosis." | 7.96 | In vitro and in vivo antimicrobial activities of a novel piperazine-containing benzothiazinones candidate TZY-5-84 against Mycobacterium tuberculosis. ( Chen, X; Fu, L; Guo, S; Liu, M; Lu, Y; Wang, B; Zhao, J, 2020) |
| "A piperazine-containing benzothiazinones lead compound PBTZ169, served as DprE1 inhibitor, displays nanomolar bactericidal activity against Mycobacteria tuberculosis." | 3.96 | In vitro and in vivo antimicrobial activities of a novel piperazine-containing benzothiazinones candidate TZY-5-84 against Mycobacterium tuberculosis. ( Chen, X; Fu, L; Guo, S; Liu, M; Lu, Y; Wang, B; Zhao, J, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, S | 1 |
| Fu, L | 1 |
| Wang, B | 1 |
| Chen, X | 1 |
| Zhao, J | 1 |
| Liu, M | 1 |
| Lu, Y | 1 |
| Girase, PS | 1 |
| Dhawan, S | 1 |
| Kumar, V | 1 |
| Shinde, SR | 1 |
| Palkar, MB | 1 |
| Karpoormath, R | 1 |
| Patel, KN | 1 |
| Telvekar, VN | 1 |
| Peng, CT | 1 |
| Gao, C | 1 |
| Wang, NY | 1 |
| You, XY | 1 |
| Zhang, LD | 1 |
| Zhu, YX | 1 |
| Xv, Y | 1 |
| Zuo, WQ | 1 |
| Ran, K | 1 |
| Deng, HX | 1 |
| Lei, Q | 1 |
| Xiao, KJ | 1 |
| Yu, LT | 1 |
| Chandran, M | 1 |
| Renuka, J | 1 |
| Sridevi, JP | 1 |
| Pedgaonkar, GS | 1 |
| Asmitha, V | 1 |
| Yogeeswari, P | 1 |
| Sriram, D | 1 |
| ZIERSKI, M | 1 |
| BUKALSKA, Z | 1 |
1 review available for piperazine and Koch's Disease
| Article | Year |
|---|---|
An appraisal of anti-mycobacterial activity with structure-activity relationship of piperazine and its analogues: A review.
Topics: Animals; Antitubercular Agents; Drug Design; Drug Discovery; Humans; Mycobacterium tuberculosis; Pip | 2021 |
5 other studies available for piperazine and Koch's Disease
| Article | Year |
|---|---|
In vitro and in vivo antimicrobial activities of a novel piperazine-containing benzothiazinones candidate TZY-5-84 against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Dose-Response Relationship, Drug; Female; Macrophages; Male; Mice; M | 2020 |
Design, synthesis and antitubercular evaluation of novel series of N-[4-(piperazin-1-yl)phenyl]cinnamamide derivatives.
Topics: Antitubercular Agents; Cinnamates; Drug Design; Humans; Microbial Sensitivity Tests; Mycobacterium t | 2014 |
Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Dose-Response Relationship, Drug; Microbial Se | 2015 |
Benzothiazinone-piperazine derivatives as efficient Mycobacterium tuberculosis DNA gyrase inhibitors.
Topics: Antitubercular Agents; Bacterial Proteins; Benzothiadiazines; DNA Gyrase; Drug Design; Humans; Mycob | 2015 |
[Value of piperazine amide in the treatment of pulmonary tuberculosis].
Topics: Amides; Piperazine; Piperazines; Tuberculosis; Tuberculosis, Pulmonary | 1961 |